Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
120.5 EUR | +2.99% | -1.63% | -0.41% |
Mar. 19 | Futures passive; BoJ abandons negative rates. | AN |
Mar. 18 | Milan at parity; De Nora on bottom after accounts | AN |
Valuation
Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 22.62 | 22.53 | - | - |
Enterprise Value (EV) 1 | 31.93 | 24.35 | 22.53 | 22.53 |
P/E ratio | 13.9 x | 5.74 x | - | - |
Yield | - | - | - | - |
Capitalization / Revenue | 0.63 x | 0.54 x | 0.49 x | 0.45 x |
EV / Revenue | 0.9 x | 0.59 x | 0.49 x | 0.45 x |
EV / EBITDA | 4.04 x | 3.13 x | 1.89 x | 1.72 x |
EV / FCF | 15 x | 6.98 x | 16.3 x | 7.22 x |
FCF Yield | 6.68% | 14.3% | 6.13% | 13.8% |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 187 | 187 | - | - |
Reference price 2 | 121.0 | 120.5 | 120.5 | 120.5 |
Announcement Date | 3/9/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | 35.67 | 41.58 | 45.74 | 50.31 |
EBITDA 1 | - | 7.9 | 7.77 | 11.93 | 13.12 |
EBIT 1 | - | 3.76 | 6.59 | 10.81 | 11.89 |
Operating Margin | - | 10.54% | 15.85% | 23.63% | 23.63% |
Earnings before Tax (EBT) 1 | 5.455 | 3.297 | 5.77 | - | - |
Net income 1 | 3.697 | 1.646 | 4.04 | - | - |
Net margin | - | 4.62% | 9.72% | - | - |
EPS 2 | - | 8.700 | 21.00 | - | - |
Free Cash Flow 1 | - | 2.134 | 3.49 | 1.38 | 3.12 |
FCF margin | - | 5.98% | 8.39% | 3.02% | 6.2% |
FCF Conversion (EBITDA) | - | 27.01% | 44.92% | 11.57% | 23.78% |
FCF Conversion (Net income) | - | 129.6% | 86.39% | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 3/29/23 | 3/9/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | - | 9.3 | 1.82 | - | - |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 1.178 x | 0.2342 x | - | - |
Free Cash Flow 1 | - | 2.13 | 3.49 | 1.38 | 3.12 |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | - | 1.4 | 3.44 | 3.68 |
Capex / Sales | - | - | 3.37% | 7.52% | 7.31% |
Announcement Date | 3/29/23 | 3/9/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.41% | 23.72M | |
-10.34% | 5.98B | |
-3.96% | 1.21B |
- Stock Market
- Equities
- HI Stock
- Financials Health Italia S.p.A.